Skip to the content
logo mainlogo darklogo light
Search
logo main
  • About us
    • Company profile
    • Facilities
    • Quality
    • Human Resources
    • People
    • The Group
  • Bioanalytical Laboratory
    • Bioanalytical Laboratory Services
    • ASSAYS CATALOGUE
      • All Assays
      • Viral Assays
      • Bacterial Assays
      • Cell Mediated Immunity (CMI)
      • Multiparametric Assays
      • Genomics
      • Molecular Biology
  • Central Laboratory
    • Central Laboratory Services
    • SERVICES
      • All Services
      • Assay Development and Validation
      • Biorepository and Samples Storage
      • Biostatistical support
      • Data Management
      • Kits Production
      • Label Printing
      • Pre-clinical Services
      • Project Management
      • Protocol Review
      • Samples Shipment
      • Scientific Support
      • Tech Transfer
      • Trainings
  • Collaborations
    • Partnerships
    • Research Projects
  • News & Media
    • PUBLICATIONS
      • All
      • Influenza
      • SARS-COV-2
      • RSV
      • hMPV
      • Monkeypox / Vaccinia
      • Flaviviruses
      • Rhabdoviruses
      • Bacteria
      • Cell-Mediated Immunity
      • Collaborative studies
      • Vaccines and clinical preclinical studies
    • News
    • Logo
    • Brochures
HomePublicationshMPV
Publications

hMPV

okequellogiusto
16 Giugno 2026

Design and validation of a semi-quantitative microneutralization assay for human Metapneumovirus A1 and B1 subtypes.

Riolo G, Biagini V, Guerrini N, Roscia G, Antonelli R, Giglioli G, Stincarelli MA, Piu P, Bonifazi C, De Grazia S, Pizzo M, Lovreglio P, Stufano A, Trombetta CM, Manenti A, Montomoli E, Dapporto F. Sci Rep. 2025 Apr 4;15(1):11614. doi: 10.1038/s41598-025-96567-6. PMID: 40185841. PMCID: PMC11971440.



Share share
  • .face-icon{fill:#fff;}
  • .tw-icon{fill:#fff;}
  • .ln-icon{fill:#fff;}
Previous post
Monkeypox / Vaccinia
Next post
RSV

Related articles

Publications
SARS-COV-2
okequellogiusto
16 Giugno 2026
Publications
RSV
okequellogiusto
16 Giugno 2026
Publications
Influenza
okequellogiusto
16 Giugno 2026

Work with us

  • Find out about opening job positions at VisMederi.
    You can send your CV along with a Handling of Personal Information Statement
    of Consent at the following e-mail address: HR@vismederi.com

Contacts

  • vismederi@pec.it
  • info@vismederi.com
  • GET IN TOUCH

Headquarter

  • Via Franco Ferrini 53
    Loc. Tognazza, San Martino
    53035 Monteriggioni
    Siena, Italy
  • phone +39 0577 1520990

Laboratories

  • Zona Industriale Belvedere
    Ingresso n. 2
    53034 Colle di Val D’Elsa
    Siena, Italy
  • phone +39 0577 1870638

Legal Headquarter

  • Colle di Val D’Elsa
    Siena, Italy

PRIVACY

  • Privacy
  • Privacy Policy
  • Cookie Policy

OTHER

  • Whistleblowing
  • Organisational Model 231
    (only in italian language)
  • Ethical code
    (only in italian language)

© 2026 VisMederi Srl - P. Iva 01269140529 - All Rights Reserved. Credits

Back to top Drag
w
  • About us
    • Company profile
    • Facilities
    • Quality
    • Human Resources
    • People
    • The Group
  • Bioanalytical Laboratory
    • Bioanalytical Laboratory Services
    • ASSAYS CATALOGUE
      • All Assays
      • Viral Assays
      • Bacterial Assays
      • Cell Mediated Immunity (CMI)
      • Multiparametric Assays
      • Genomics
      • Molecular Biology
  • Central Laboratory
    • Central Laboratory Services
    • SERVICES
      • All Services
      • Assay Development and Validation
      • Biorepository and Samples Storage
      • Biostatistical support
      • Data Management
      • Kits Production
      • Label Printing
      • Pre-clinical Services
      • Project Management
      • Protocol Review
      • Samples Shipment
      • Scientific Support
      • Tech Transfer
      • Trainings
  • Collaborations
    • Partnerships
    • Research Projects
  • News & Media
    • PUBLICATIONS
      • All
      • Influenza
      • SARS-COV-2
      • RSV
      • hMPV
      • Monkeypox / Vaccinia
      • Flaviviruses
      • Rhabdoviruses
      • Bacteria
      • Cell-Mediated Immunity
      • Collaborative studies
      • Vaccines and clinical preclinical studies
    • News
    • Logo
    • Brochures